Detecting DNA Methylation of the BCL2, CDKN2A and NID2 Genes in Urine Using a Nested Methylation Specific Polymerase Chain Reaction Assay to Predict Bladder Cancer
Keywords: DNA methylation; urinary bladder neoplasms; polymerase chain reaction; ACTB; β-actin; BCL2; B-cell lymphoma 2; CDKN2A; cyclin dependent kinase inhibitor 2A; LMP; low malignancy potential; MSP; methylation specific polymerase chain reaction; NID2; Nidogen